Business

Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System

Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic investment from Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (“JJDC”). This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capit

articleJohnson & JohnsonJanuary 12, 20265/company/johnson-and-johnson/news/distalmotion-secures-strategic-investment-to-advance-asc-expansion-of-the-dexterr-robotic-surgery-system
Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System

About this update from Johnson & Johnson

[{"type":"text","content":"Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System","length":104,"tagName":"p"},{"type":"image","alt":"Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic investment from Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (“JJDC”). This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capital. Distalmotion focuses on the growing need for a purpose-built robotic platform designed for Ambulatory Surgery Centers (ASCs).","displaySize":"","headline":null,"caption":"Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic investment from Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (“JJDC”). This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capital. Distalmotion focuses on the growing need for a purpose-built robotic platform designed for Ambulatory Surgery Centers (ASCs).","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":2363,"height":1772,"url":"https://media.zenfs.com/en/globenewswire.com/2a93e7ecb8fa887f8c222dbc9db586a4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/4VG5hFNebLWdVhi.Z2IewQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTcyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2a93e7ecb8fa887f8c222dbc9db586a4","width":960,"height":720},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/w.fuWi78FSs38vCvsrkHnQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xODAwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/2a93e7ecb8fa887f8c222dbc9db586a4","width":1200,"height":900}}},{"type":"text","content":"About DEXTER","length":12,"tagName":"p"},{"type":"image","alt":"The DEXTER® Robotic Surgery System is a soft tissue surgical robot that uniquely simplifies operations to make the benefits of wristed robotics accessible in any operating room (OR). DEXTER comes with a suite of fully wristed single use robotic instruments that enhance dexterity and precision. A smal...

More updates from Johnson & Johnson

Johnson & JohnsonDEXTERRobotic SurgeryRevival Healthcare Capitalcorporate venture capitalGreg Roche DistalmotionJJDCJJDC, IncMedTech